ALZN stock news · Alzamend Neuro

Stories about Alzamend Neuro (ALZN) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for ALZN

Follow Alzamend Neuro (ALZN) free. When we publish a story about it, you get the plain-English explanation as an alert.

Free on the App Store and Google Play, or on the web.

Oct 23, 2026, 8:20 AM ET · Market
12 health care companies are changing a lot in Friday's early trading.
Neutral
Alzamend Neuro's shares rose about 12% to $1.25 in Friday's pre-market session. The report gives no company update, so the move alone does not change Alzamend Neuro's business outlook.
Sep 29, 2026, 6:35 AM ET · Market
Alzamend Neuro, Inc. says Dr. Ovidiu C. Andronesi will speak at the ISMRT Conference.
Neutral
Alzamend Neuro filed a report about its trial investigator's conference presentation. It shares no new patient findings, so the filing does not change the company's outlook.